Function of Renal Transplant Clinical Trial
Official title:
A Randomized Trial of Rituximab in Induction Therapy for Living Donor Renal Transplantation
Hypothesis:
- That B cell depletion, rather than reducing acute rejection, will allow minimisation of
immunosuppression, which may lead to better graft survival.
Aim:
- To assess whether the addition of rituximab to a low-dose tacrolimus immunosuppression
regime allows a reduction in steroid administration.
Objectives:
- To assess whether B cell depletion affects graft function, acute rejection and
complication rates
- To assess whether the T cell response to allotransplantation is impaired by B cell
depletion.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01443013 -
Analysis of Foxp3 and Vimentin Expression in Renal Transplant Recipient
|
N/A | |
| Completed |
NCT01759862 -
Perioperative Aminophylline to Improve Early Kidney Function After a Kidney Transplant
|
N/A | |
| Terminated |
NCT01292525 -
Protocol Calcineurin Inhibitor (CNI) Weaning
|
Phase 3 | |
| Completed |
NCT00223054 -
Polymorphism of the Cytochrome P450-system in Renal Transplants
|
Phase 4 |